Imdelltra® (tarlatamab-dlle)
for Lung Cancer

Imdelltra (tarlatamab-dlle) is an immunotherapy for adults with extensive-stage small cell lung cancer (ES-SCLC) that has progressed after platinum-based chemotherapy. It’s a bispecific T-cell engager that binds DLL3 on tumor cells and CD3 on T-cells, bringing them together to activate the immune system at the cancer site.

Heart